1. Home
  2. YDES vs NPCE Comparison

YDES vs NPCE Comparison

Compare YDES & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

YDES

YD Bio Limited Ordinary Shares

N/A

Current Price

$2.99

Market Cap

543.0M

Sector

N/A

ML Signal

N/A

Logo Neuropace Inc.

NPCE

Neuropace Inc.

N/A

Current Price

$14.65

Market Cap

537.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
YDES
NPCE
Founded
2013
1997
Country
Taiwan
United States
Employees
N/A
N/A
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
543.0M
537.0M
IPO Year
2024
2021

Fundamental Metrics

Financial Performance
Metric
YDES
NPCE
Price
$2.99
$14.65
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$18.33
AVG Volume (30 Days)
29.5K
222.6K
Earning Date
05-12-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
29.03
EPS
N/A
N/A
Revenue
N/A
$99,986,000.00
Revenue This Year
N/A
$0.90
Revenue Next Year
N/A
$24.46
P/E Ratio
N/A
N/A
Revenue Growth
N/A
25.13
52 Week Low
$1.70
$8.19
52 Week High
$25.00
$19.60

Technical Indicators

Market Signals
Indicator
YDES
NPCE
Relative Strength Index (RSI) 61.32 47.37
Support Level $2.88 $13.84
Resistance Level $5.36 $14.72
Average True Range (ATR) 0.30 0.84
MACD 0.09 0.11
Stochastic Oscillator 93.52 61.51

Price Performance

Historical Comparison
YDES
NPCE

About YDES YD Bio Limited Ordinary Shares

YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.

About NPCE Neuropace Inc.

NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.

Share on Social Networks: